Review: taking Pepcid ac and Tysabri together


Summary

Drug interactions are reported among people who take Pepcid ac and Tysabri together. This review analyzes the effectiveness and drug interactions between Pepcid ac and Tysabri. It is created by eHealthMe based on reports of 171 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Pepcid ac and Tysabri >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Pepcid Ac

Pepcid ac has active ingredients of famotidine. It is often used in gastrooesophageal reflux disease. (latest outcomes from Pepcid ac 3,423 users)

Tysabri

Tysabri has active ingredients of natalizumab. It is often used in multiple sclerosis. (latest outcomes from Tysabri 133,866 users)

On Aug, 24, 2016

171 people who take Pepcid Ac, Tysabri are studied.


Number of reports submitted per year:

Pepcid ac and Tysabri drug interactions.

Most common drug interactions over time *:

< 1 month:
  • device related infection
  • dyspnoea
  • lethargy
  • localised infection
  • nausea
  • septic encephalopathy
  • staphylococcal sepsis
  • thrombocytopenia
  • urinary tract infection
  • urticaria
1 - 6 months:
  • hypersensitivity
  • necrotising colitis
  • abscess fungal
  • enterococcal infection
  • osteoporosis
  • abdominal sepsis
  • depression
  • dyspnoea
  • hypotension
  • postoperative abscess
6 - 12 months:
  • astrocytoma
  • cognitive disorder
  • multiple sclerosis relapse
  • pregnancy
  • urinary tract infection
  • abulia
  • asthenia
  • blindness unilateral
  • depression
  • fall
1 - 2 years:
  • fall
  • femur fracture
  • hypoaesthesia
  • muscular weakness
  • papillary thyroid cancer
  • rash pruritic
  • somnolence
  • urticaria
  • acute respiratory failure
  • arthritis
2 - 5 years:
  • multiple sclerosis relapse
  • urinary tract infection
  • fall
  • sepsis
  • cryptococcal fungaemia
  • cystitis
  • meningitis cryptococcal
  • mood swings
  • pain
  • psychotic behaviour
5 - 10 years:
  • progressive multifocal leukoencephalopathy
  • hyperglycaemia
  • rash
  • abasia
  • amnesia
  • arrhythmia
  • balance disorder
  • diarrhoea
  • diplopia
  • drug ineffective
10+ years:
  • anxiety
  • back pain
  • cardiac disorder
  • cerebral haemorrhage
  • compression fracture
  • depression
  • emotional distress
  • foot fracture
  • gallbladder disorder
  • hip fracture
not specified:
  • fatigue
  • multiple sclerosis relapse
  • dizziness
  • depression
  • urinary tract infection
  • gait disturbance
  • headache
  • hypoaesthesia
  • pain
  • osteoporosis

Most common drug interactions by gender *:

female:
  • urinary tract infection
  • multiple sclerosis relapse
  • dizziness
  • fatigue
  • headache
  • depression
  • hypertension
  • dyspnoea
  • fall
  • hypoaesthesia
male:
  • asthenia
  • fatigue
  • depression
  • gait disturbance
  • hypoaesthesia
  • fall
  • pain
  • sinusitis
  • multiple sclerosis relapse
  • sepsis

Most common drug interactions by age *:

10-19:
  • abdominal pain
  • crohn's disease
  • hepatic enzyme increased
  • procedural pain
20-29:
  • pregnancy
  • chronic obstructive pulmonary disease
  • multiple fractures
  • multiple sclerosis relapse
  • osteoporosis
  • pain
  • arthritis
  • bone pain
  • cardiac disorder
  • cataract
30-39:
  • multiple sclerosis relapse
  • fatigue
  • headache
  • hypoaesthesia
  • urinary tract infection
  • astrocytoma
  • dyspnoea
  • affective disorder
  • anxiety
  • chest discomfort
40-49:
  • depression
  • muscle spasms
  • back pain
  • osteoporosis
  • urinary tract infection
  • anxiety
  • cryptococcal fungaemia
  • headache
  • hypersensitivity
  • meningitis cryptococcal
50-59:
  • depression
  • hypoaesthesia
  • paraesthesia
  • asthenia
  • fatigue
  • pain
  • urinary tract infection
  • fall
  • balance disorder
  • dizziness
60+:
  • fall
  • dizziness
  • transient ischaemic attack
  • cerebrovascular accident
  • multiple sclerosis relapse
  • fatigue
  • cerebral haemorrhage
  • hypertension
  • visual impairment
  • gait disturbance

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Pepcid ac and Tysabri?

Can you answer these questions?

More questions for: Pepcid ac, Tysabri

You may be interested in these reviews

More reviews for: Pepcid ac, Tysabri

On eHealthMe, Pepcid ac (famotidine) is often used to treat gastrooesophageal reflux disease. Tysabri (natalizumab) is often used to treat multiple sclerosis. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.